Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bone Biologics's operating cash flow for the twelve months ending Sep 30, 2026 was -$2.57M. For fiscal 2025 it was -$2.69M. The highest annual figure on record is -$3.60K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.69M | – |
| FY2024 | Dec 31, 2024 | -$4.12M | – |
| FY2023 | Dec 31, 2023 | -$9.56M | – |
| FY2022 | Dec 31, 2022 | -$3.57M | – |
| FY2021 | Dec 31, 2021 | -$1.23M | – |
| FY2020 | Dec 31, 2020 | -$426.93K | – |
| FY2019 | Dec 31, 2019 | -$3.25M | – |
| FY2018 | Dec 31, 2018 | -$4.10M | – |
| FY2017 | Dec 31, 2017 | -$3.33M | – |
| FY2016 | Dec 31, 2016 | -$7.33M | – |
| FY2015 | Dec 31, 2015 | -$3.55M | – |
| FY2014 | Dec 31, 2014 | -$2.76M | – |
| FY2012 | Oct 31, 2012 | -$6.06K | – |
| FY2011 | Oct 31, 2011 | -$3.60K | – |
| FY2010 | Oct 31, 2010 | -$5.68K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$532.28K | – |
| Q2 FY2026 | Jun 30, 2026 | -$518.44K | – |
| Q1 FY2026 | Mar 31, 2026 | -$804.28K | – |
| Q4 FY2025 | Dec 31, 2025 | -$714.76K | – |
| Q3 FY2025 | Sep 30, 2025 | -$591.38K | – |
| Q2 FY2025 | Jun 30, 2025 | -$458.88K | – |
| Q1 FY2025 | Mar 31, 2025 | -$926.13K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$572.16K | – |
| Q2 FY2024 | Jun 30, 2024 | -$895.87K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.30M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.02M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.56M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.63M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$360.06K | – |
| Q1 FY2022 | Mar 31, 2022 | -$860.78K | – |
| Q4 FY2021 | Dec 31, 2021 | -$186.85K | – |
| Q3 FY2021 | Sep 30, 2021 | -$277.77K | – |
| Q2 FY2021 | Jun 30, 2021 | -$635.98K | – |
| Q1 FY2021 | Mar 31, 2021 | -$127.98K | – |
| Q4 FY2020 | Dec 31, 2020 | -$125.69K | – |
| Q3 FY2020 | Sep 30, 2020 | -$72.23K | – |
| Q2 FY2020 | Jun 30, 2020 | -$79.13K | – |
| Q1 FY2020 | Mar 31, 2020 | -$149.88K | – |
| Q4 FY2019 | Dec 31, 2019 | -$297.69K | – |
| Q3 FY2019 | Sep 30, 2019 | -$474.54K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.55M | – |
| Q1 FY2019 | Mar 31, 2019 | -$928.97K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.34M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.28M | – |
| Q2 FY2018 | Jun 30, 2018 | -$666.84K | – |
| Q1 FY2018 | Mar 31, 2018 | -$818.88K | – |
| Q4 FY2017 | Dec 31, 2017 | -$931.70K | – |
| Q3 FY2017 | Sep 30, 2017 | -$561.04K | – |
| Q2 FY2017 | Jun 30, 2017 | -$829.32K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.01M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.27M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.51M | – |
See a number that looks wrong?